- Mylotarg pulled from market (1 replies)
- Side effects of Vidaza (58 replies)
- dacogen treatment problems, any ideas ??? (3 replies)
- New drug in trial (Belinostat + Velcade) (0 replies)
- Sapacitabine shows 35% improved patients (0 replies)
- ATG with Cyclosporine (2 replies)
- New drug ESTYBON for Vidaza and Dacogen resistent patients (13 replies)
- More effective Vidaza in the future (5 replies)
- Exjade (1 replies)
- Vidaza and Dacogen (10 replies)
- Vidaza rash? (1 replies)
- No Vidaza in Scotland (0 replies)
- Vidaza working great so far (9 replies)
- NPlate for Aplastic Anemia? (0 replies)
- MDS starting Revlimid--Side effects???? (2 replies)
- Dacogen during 5 days (4 replies)
- No Vidaza in the UK? (4 replies)
- Exjade FDA warning update (2 replies)
- New here and confused of course (5 replies)
- IVIG (7 replies)
- brands of cyclosporne (6 replies)
- low dose naltrexone (58 replies)
- MDS: Adding Neupogen to Vidaza/Procrit: Anyone have experience? (2 replies)
- Alemtuzumab (Campath) Effective in MDS (3 replies)
- Cyclosporine Shortage? (2 replies)
- Can vidaza cause big drops in counts? (20 replies)
- Long Term vidaza use?? (4 replies)
- Platelet drug (eltrombopag/Promacta) for MDS patients (4 replies)
- Vidaza and Epival/Depakene (5 replies)
- Vidaza 5 days vs 7 days (11 replies)
- Vidaza not working (5 replies)
- MDS Starting Vidaza: What to expect? (49 replies)
- Correlation between gene expression and Vidaza responsiveness (0 replies)
- Revlimid (1 replies)
- Cyclosporine and fungal infections (4 replies)
- Individual drug response (2 replies)
- Vidaza vs. Dacogen (11 replies)
- Who will respond to Vidaza? (1 replies)
- What is the Vidaza procedure? (2 replies)
- No Vidaza in the UK? (4 replies)
- Promacta for Platelets (13 replies)
- Results with TLK199 (0 replies)
- Oral Vidaza (3 replies)
- Neupogen (1 replies)
- Cyclosporine: best scheme of intake (7 replies)
- Dacogen during 5 days instead of 3 days (0 replies)
- Vidaza (2 replies)
- Study about Vidaza vs Dacogen (4 replies)
- Using Dacogen for Long-Term Care (0 replies)
- Article about TKL-199 (0 replies)
- Megace/Oxandrin (3 replies)
- Recent article about treatment for MDS (0 replies)
- Cyclosporine dosage and troughs (11 replies)
- Vidaza vs Dacogen (0 replies)
- Thalidomide best for recently dx patients that only have anemia (0 replies)
- Special changes that can lead to AML (4 replies)
- Cyclosporine + fluconazole (4 replies)
- Revlimid (13 replies)
- ? reaction to midazolam (1 replies)
- Report from the MDS Foundation Symposium (0 replies)
- Imuran vs. generic? (2 replies)
- For Helen about Telintra (2 replies)
- kidney problems with cyclosporine (4 replies)
- Revlimid and low risk/high risk MDS (2 replies)
- Problems with Procrit (19 replies)
- Problems with Vidaza (0 replies)
- Nausea and chemo Aloxi better than Zofran (0 replies)
- Exjade and counts (0 replies)
- Sapacitabine a new drug for MDS? (0 replies)
- Revlimid response, low platelets and transfusion independence (1 replies)
- Nellie's Journey on Vidaza (120 replies)
- The Doctor Came In Smileing Ear To Ear! (2 replies)
- Vidaza in EU at last! (0 replies)
- 2nd round of dacogen (2 replies)
- Promacta (Eltrombopag) and bone marrow (0 replies)
- Promacta for low platelets approved by FDA (1 replies)
- Leftover Cyclosporine (5 replies)
- Starting on Dacogen (2 replies)
- Vidaza soon in EU (2 replies)
- Has anyone been on Dacogen plus valproic acid? (1 replies)
- Exjade (1 replies)
- Clinical protocols (8 replies)
- Vitamin C may blunt effect of chemotherapy (0 replies)
- New drug, ON 01910. Na, for MDS in Phase I trial (9 replies)
- Fatigue with Aransep? (1 replies)
- New drug - sapacitabine - in phase II trial (1 replies)
- About treatment with Revlimid (lenalidomide) and EPO (2 replies)
- FDA approval for drug for low platelets (1 replies)
- Vidaza receives expanded FDA approval (4 replies)
- Pulling Procrit (3 replies)
- New drug - MGCD0103 - can give heart symptoms (0 replies)
- Lytoxan chemotherapy treatment desperately sought (4 replies)
- Website with Adverse effects data (2 replies)
- Side Effects of Revlimid (2 replies)
- treatment for low wbcs? (1 replies)
- Revlimid not approved for MDS in EU due to risk for AML (2 replies)
- New drug, Ceplene, could prevent ralapse of AML (0 replies)
- aranesp for mds (9 replies)
- idarubensin ara-c (3 replies)
- Need info regarding Vidaza treatment (12 replies)